Followers | 63 |
Posts | 8502 |
Boards Moderated | 0 |
Alias Born | 01/10/2014 |
Tuesday, March 03, 2020 10:42:30 AM
10:22 am ET March 3, 2020 (Benzinga) Print
GenMark Diagnostics, Inc (NASDAQ: GNMK) shares, where were languishing around 52-week lows, found support Tuesday from COVID-19 related news.
The Carlsbad, California-based provider of automated, multiplex molecular diagnostic testing systems announced initial shipments of ePlex Research Use Only test kits designed to detect COVID-19 virus to its Hong Kong distributor as well as several U.S. customers that have access to clinical samples.
The company said it plans to use this information to support submission of an Emergency Use Authorization, or EUA, to the FDA.
“Believing in negative thoughts is the single greatest obstruction to success.”
Charles F. Glassman
Statements made are only my opinion. Do your own DD in order to make your own investment decisions.
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM
HealthLynked Corp Announces First Quarter 2024 Results: Achieves 8% Revenue Growth Over Last Quarter • HLYK • May 16, 2024 8:00 AM
Integrated Ventures Files Q3/2024 With Mining Revenues Of $1,983,250 And Positive Earnings Of $0.05 Cents Per Share • INTV • May 15, 2024 10:30 AM